Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.

Nádia Emi AikawaLeonard de Vinci Kanda KupaAna Cristina Medeiros-RibeiroCarla Goncalves Schahin SaadEmily Figueiredo Neves YukiSandra Gofinet PasotoPriscila Tagliaferro RojoRosa Maria Rodrigues PereiraSamuel Katsuyuki ShinjoPercival Degrava Sampaio-BarrosDanieli Castro de Oliveira AndradeAri Stiel Radu HalpernRicardo FullerFernando Henrique Carlos SouzaLissiane Karine Noronha GuedesAna Paula Luppino AssadJulio Cesar Bertacini de MoraesMichelle Remiao Ugolini LopesVictor Adriano de Oliveira MartinsLorena BetancourtCarolina Torres RibeiroLucas Peixoto SalesIsabela Maria BertoglioVirginia Lucia Nazario BonoldiRenata Lys Pinheiro MelloGustavo Guimaraes Moreira BalbiAna Marli Christovam SartoriLeila AntonangeloClóvis Artur SilvaEloisa S Bonfa

Published in: Annals of the rheumatic diseases (2022)

NCT04754698.

Keyphrases

sars cov
respiratory syndrome coronavirus
dna repair
multiple sclerosis
dna damage